Skip to Main Content

The Swiss attorney general is eyeing the $1.2 million deal that Novartis made with Michael Cohen, President Trump’s personal lawyer, but is not conducting any criminal probe at this time, according to a statement from the federal prosecutor.

As reported last week, Cohen approached Novartis in early 2017 to offer access to the new Trump administration. And Joe Jimenez, who was chief executive officer at the drug maker at the time, agreed to a one-year, $1.2 million contract, even though Cohen is not a registered lobbyist or an expert in health care policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!